Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Compliant Monitoring of Adverse Events

Posted on May 24th, 2017 by in Pharmacovigilance

Developing and maintaining a solid strategy for screening for adverse events is critical for every pharmaceutical company. Without one, an adverse event could be reported in scientific literature without the company knowing — and failure to report it to the regulatory authorities could result in a serious warning. Continue reading “Compliant Monitoring of Adverse Events” »

How Are You Handling Big Data & Innovation?

Posted on April 28th, 2017 by in Pharma R&D

Although every pharmaceutical company still hopes to find the next blockbuster drug, today’s R&D departments are becoming increasingly focused on developing more targeted therapies. It is the advent of Big Data that has made it possible for researchers to advance precision medicine and targeted drugs Continue reading “How Are You Handling Big Data & Innovation?” »

Mergers and Acquisitions in the Pharma Industry

Posted on February 8th, 2017 by in Pharma R&D

It seems we cannot go a month without seeing in the news another acquisition by a big pharmaceutical company. Continue reading “Mergers and Acquisitions in the Pharma Industry” »

New Hive Participants Tackle Unmet Needs

Posted on October 20th, 2016 by in Pharma R&D

When Elsevier R&D Solutions launched its new initiative, dubbed The Hive, earlier this year, its aim was to identify a handful of bright biotech start-ups to participate in a collaborative effort designed to boost early stage drug discovery and development. Continue reading “New Hive Participants Tackle Unmet Needs” »

  1. 1
  2. 2